ET 007

Drug Profile

ET 007

Alternative Names: Anti-HIV drug - Endocrine Technology; HIV antiviral drug - Endocrine Transplant

Latest Information Update: 24 Apr 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Endocrine Technology LLC
  • Class
  • Mechanism of Action HIV envelope protein gp120 inhibitors; HIV envelope protein gp41 inhibitors; Human immunodeficiency virus tat gene product inhibitors; Immunostimulants; RNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 24 Apr 2007 Discontinued - Preclinical for HIV infections prevention in USA (unspecified route)
  • 24 Apr 2007 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
  • 18 Feb 2002 Preclinical development for HIV infections prevention in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top